ACTRN12620001173987Active, not recruiting未知
Optimising outcomes for frail hospitalised older adults – nurse led volunteer support and pain assessment interventions: A cluster randomised control trial
Trial Snapshot
- Phase
- 未知
- Status
- Active, not recruiting
- Sponsor
- Edith Cowan University
- Enrollment
- 421
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Prevention
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- 65 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •Patients aged 65 years and over admitted to participating wards
- •Anticipated length of hospital stay 48 hours or longer
- •Score greater than or equal to 8 on the modified-Reported Edmonton Frail Scale (mod-REFS)
Exclusion Criteria
- •Non-medical patient
- •Severe intellectual disability
- •Patients who requires isolation due to infection control precautions
Investigators
Similar Trials
Completed
Not Applicable
Optimising acute delirium care in Tan Tock Seng HospitalISRCTN52323811Ministry of Health (Singapore)200
Completed
Not Applicable
Developing better care for the elderly patients with walking disability due to degenerative lumbar spine stenosisISRCTN35836727Record Provided by the NHSTCT Register - 2006 Update - Department of Health20
Completed
Not Applicable
Minimising functional decline amongst older adults with a novel intervention against a traditional intervention.ACTRN12610000909022Singhealth Foundation40
Active, not recruiting
Phase 1
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.EUCTR2016-002272-27-BESaarland University388
Active, not recruiting
Phase 1
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.Patients with first relapse or progression of aggressive Non-Hodgkin’s Lymphoma who are not eligible neither for autologous nor allogeneic stem cell transplantationMedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-002272-27-ATSaarland University388